Hybrid Imaging Modalities for the Evaluation of Infection

This study has been completed.
Sponsor:
Information provided by:
Rambam Health Care Campus
ClinicalTrials.gov Identifier:
NCT00230152
First received: September 29, 2005
Last updated: October 21, 2010
Last verified: September 2005

September 29, 2005
October 21, 2010
February 2006
April 2007   (final data collection date for primary outcome measure)
The impact of the imaging modality on patient management [ Time Frame: 3 years ] [ Designated as safety issue: No ]
The impact of the imaging modality on patient management
Complete list of historical versions of study NCT00230152 on ClinicalTrials.gov Archive Site
The impact of the imaging modality on patient management [ Time Frame: 2 years ] [ Designated as safety issue: No ]
Not Provided
Not Provided
Not Provided
 
Hybrid Imaging Modalities for the Evaluation of Infection
Nuclear Medicine for the Evaluation of Infection-the Added Value of Hybrid Imaging Modalities

The synergistic value of the fusion of physiologic and anatomical data has been described using several co-registration techniques for various nuclear medicine procedures and morphologic imaging modalities (single photon emission computed tomography-computed tomography [SPECT-CT], SPECT-magnetic resonance imaging [MRI], camera-based positron emission tomography [PET]-CT and PET-CT). The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired sequentially in a single imaging session on one device is clinically superior to side-by-side evaluation of separately performed imaging tests. They hypothesize that more accurate localization of increased radiotracer activity on NM procedures will improve the diagnostic accuracy for detection of infection and will subsequently have a significant impact on patient management.

The purpose of the present study is to assess the clinical value of this new technology of fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of an infection process.

The researchers hypothesize that fusion of nuclear medicine (NM) and CT data acquired sequentially in a single imaging session on one device is clinically superior to side-by-side evaluation of separately performed imaging tests. They hypothesize that more accurate localization of increased radiotracer activity on NM procedures will improve the diagnostic accuracy for detection of infection and will subsequently have a significant impact on patient management.

The purpose of the present study is to assess the clinical value of this new technology of fused imaging in patients undergoing diagnostic nuclear medicine evaluation for suspicion of an infection process.

Interventional
Not Provided
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Diagnostic
Infectious Diseases
Device: Imaging
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
March 2009
April 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Patients referred for NM imaging procedures to assess the presence of infectious processes.
  • Patients signed informed consent

Exclusion Criteria:

  • The study will not be performed in pregnant or lactating women.
  • Patients unable or unwilling to tolerate the scan until its completion
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00230152
infectionCTIL
No
Rambam Health Care Campus
Rambam Health Care Campus
Not Provided
Principal Investigator: Zohar Keidar, MD, PhD Rambam Health Care Campus
Rambam Health Care Campus
September 2005

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP